Dr. Hansen Su, MD

NPI: 1952372591
Total Payments
$10,591
2024 Payments
$75.70
Companies
35
Transactions
601
Medicare Patients
1,037
Medicare Billing
$218,740

Payment Breakdown by Category

Food & Beverage$10,303 (97.3%)
Education$288.09 (2.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $10,303 591 97.3%
Education $288.09 10 2.7%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $1,974 102 $0 (2022)
Otsuka America Pharmaceutical, Inc. $1,372 59 $0 (2023)
Alkermes, Inc. $1,299 60 $0 (2023)
Teva Pharmaceuticals USA, Inc. $835.40 49 $0 (2023)
Janssen Pharmaceuticals, Inc $704.43 41 $0 (2022)
Lundbeck LLC $682.07 39 $0 (2023)
Shire North American Group Inc $425.78 33 $0 (2019)
Neurocrine Biosciences, Inc. $378.53 20 $0 (2023)
Vanda Pharmaceuticals Inc. $357.88 27 $0 (2020)
Indivior Inc. $307.42 23 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $75.70 4 E.R. Squibb & Sons, L.L.C. ($44.02)
2023 $416.58 19 Alkermes, Inc. ($109.82)
2022 $647.85 34 Sunovion Pharmaceuticals Inc. ($344.00)
2021 $576.65 30 Sunovion Pharmaceuticals Inc. ($301.44)
2020 $773.15 43 Sunovion Pharmaceuticals Inc. ($187.23)
2019 $3,418 193 Otsuka America Pharmaceutical, Inc. ($775.52)
2018 $2,381 141 Sunovion Pharmaceuticals Inc. ($464.55)
2017 $2,302 137 Alkermes, Inc. ($385.27)

All Payment Transactions

601 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
11/08/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $16.75 General
Category: Psychiatry/Psychology
10/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $27.27 General
Category: Psychiatry/Psychology
08/19/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $8.15 General
Category: CNS Stimulant for ADHD
01/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.53 General
Category: NEUROSCIENCE
12/14/2023 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.06 General
Category: NEUROSCIENCE
11/15/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.54 General
Category: Neuropsychiatry
10/12/2023 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $13.59 General
Category: ANTI-ANXIETY
10/10/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $18.62 General
Category: CNS Stimulant for ADHD
09/07/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $26.56 General
Category: CNS
08/24/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $23.39 General
Category: PSYCHIATRY
08/15/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $23.49 General
Category: PSYCHOLOGY
07/19/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.45 General
Category: Neuropsychiatry
07/11/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $18.62 General
Category: CNS
06/22/2023 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $26.28 General
Category: BH
06/13/2023 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $21.11 General
Category: Neurology
06/05/2023 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $33.59 General
Category: PSYCHIATRY
05/11/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $23.10 General
Category: CNS
05/08/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $13.59 General
Category: Central Nervous System
04/14/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.05 General
Category: CNS
04/10/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $15.65 General
Category: Central Nervous System
03/14/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $21.49 General
Category: CNS
02/16/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $22.87 General
Category: Central Nervous System
01/23/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $16.53 General
Category: Central Nervous System
12/15/2022 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.53 General
Category: NEUROSCIENCE
11/22/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $8.15 General
Category: Central Nervous System

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 147 304 $127,466 $27,166
2022 6 260 545 $133,336 $50,970
2021 5 316 727 $171,462 $74,663
2020 5 314 730 $161,549 $65,941
Total Patients
1,037
Total Services
2,306
Medicare Billing
$218,740
Procedure Codes
20

All Medicare Procedures & Services

20 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 88 242 $97,085 $17,834 18.4%
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 24 26 $21,455 $6,291 29.3%
G0426 Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth Office 2023 20 21 $5,712 $2,126 37.2%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 15 15 $3,214 $913.50 28.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 116 324 $57,840 $24,482 42.3%
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 41 45 $33,042 $10,956 33.2%
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 13 34 $17,770 $6,690 37.6%
80307 Testing for presence of drug, by chemistry analyzers Office 2022 55 84 $14,960 $5,160 34.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 42 $5,372 $1,987 37.0%
G0426 Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth Office 2022 15 16 $4,352 $1,696 39.0%
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2021 74 129 $81,528 $31,853 39.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 132 399 $59,850 $30,814 51.5%
80307 Testing for presence of drug, by chemistry analyzers Office 2021 76 145 $21,750 $9,010 41.4%
G0426 Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth Office 2021 14 16 $4,352 $1,720 39.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 20 38 $3,982 $1,266 31.8%
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2020 64 118 $74,576 $28,830 38.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 157 441 $66,150 $28,533 43.1%
80307 Testing for presence of drug Office 2020 63 115 $17,250 $7,072 41.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 14 26 $2,673 $775.34 29.0%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 16 30 $900.00 $730.80 81.2%

About Dr. Hansen Su, MD

Dr. Hansen Su, MD is a Psychiatry healthcare provider based in Hillsborough, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952372591.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hansen Su, MD has received a total of $10,591 in payments from pharmaceutical and medical device companies, with $75.70 received in 2024. These payments were reported across 601 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,303).

As a Medicare-enrolled provider, Su has provided services to 1,037 Medicare beneficiaries, totaling 2,306 services with total Medicare billing of $218,740. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Hillsborough, NC
  • Active Since 01/31/2006
  • Last Updated 09/08/2016
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1952372591

Products in Payments

  • LATUDA (Drug) $1,974
  • REXULTI (Drug) $1,058
  • ABILIFY MAINTENA (Drug) $722.77
  • ARISTADA (Drug) $687.37
  • Aristada 441 mg (Drug) $557.60
  • AUSTEDO (Drug) $554.59
  • INVEGA SUSTENNA (Drug) $446.15
  • VRAYLAR (Drug) $429.59
  • INGREZZA (Drug) $378.53
  • Fanapt (Drug) $341.35
  • VYVANSE (Drug) $292.05
  • Trintellix (Drug) $272.73
  • NUEDEXTA (Drug) $215.04
  • MYDAYIS (Drug) $186.09
  • SUBLOCADE (Drug) $178.14
  • TRINTELLIX (Drug) $169.76
  • Evekeo (Drug) $163.42
  • Adzenys XR-ODT (Drug) $161.86
  • INVEGA TRINZA (Drug) $155.68
  • Dyanavel XR (Drug) $132.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Hillsborough